BioCentury
ARTICLE | Clinical News

2-methoxyestradiol: Phase I started

April 3, 2006 7:00 AM UTC

PRP began a double-blind, placebo-controlled U.S. Phase I trial in 50 healthy volunteers to evaluate subcutaneous doses of sustained-release injectable formulation of PulmoLAR. ...